Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics to the page.
    Difference
    0.2%
    Check dated 2026-01-12T13:19:40.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Removed related topics including 'Multiple myeloma' and MedlinePlus Genetics from the page's related topics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-29T08:27:42.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added related topics 'Multiple myeloma' and 'MedlinePlus Genetics', and updated the page revision to v3.3.3. Removed the 'HHS Vulnerability Disclosure' link and the previous revision v3.3.2.
    Difference
    0.3%
    Check dated 2025-12-22T01:50:21.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing the previous Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-30T16:14:11.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Publications section now includes a note that items are automatically filled from PubMed, and a Revision: v3.3.1 was added. The earlier language about PubMed publications and related topics (including MedlinePlus Genetics) and the Revision: v3.2.0 entry were removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-23T14:53:39.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A government funding/operating status notice was removed from the page, which does not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-16T14:32:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.